Silent Cerebral Infarcts in Iraqi Patients with Sickle Cell Disease

References

• Esoh K, Wonkam A. Evolutionary history of sickle-cell mutation: implications for global genetic medicine. Hum Mol Genet. 2021;30(R1):R119–R128.doi:10.1093/hmg/ddab004.
   PubMed Web of Science ®Google Scholar
• Rees DC, Williams TN, Gladwin MT. Sickle cell disease. Lancet. 2010;376(0757):2008–2031.
   Google Scholar
• Tebbi CK. Sickle cell disease, a review. Hemato.2022;3(2):341–366.doi:10.3390/hemato3020024.
   Google Scholar
• Al-Allawi N, Al Allawi S, Jalal SD. Genetic epidemiology of hemoglobinopathies in Iraqi Kurds. J Community Genet. 2021;12(1):5–14.doi:10.1007/s12687-020-00495-z.
   PubMed Web of Science ®Google Scholar
• DeBaun MR, Armstrong D, McKinstry RC, et al. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood. 2012;119(20):4587–4596.doi:10.1182/blood-2011-02-272682.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski JL, Zimmerman RA, Pollock AN, et al. Silent infarcts in young children with sickle cell disease. Br J Haematol. 2009;146(3):300–305.doi:10.1111/j.1365-2141.2009.07753.x.
   PubMed Web of Science ®Google Scholar
• Bernaudin F, Verlhac S, Arnaud C, et al. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood. 2011;117(4):1130–1140; quiz 1436.doi:10.1182/blood-2010-06-293514.
   PubMed Web of Science ®Google Scholar
• Ahmed AJ. Clinical, hematological and molecular characterization of sickle cell disease in Duhok [master’s thesis]. Duhok: College of Medicine, University of Duhok; 2011.
   Google Scholar
• DeBaun MR, Gordon M, McKinstry RC, et al. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med. 2014;371(8):699–710.doi:10.1056/NEJMoa1401731.
   PubMed Web of Science ®Google Scholar
• Houwing ME, Grohssteiner RL, Dremmen MHG, et al. Silent cerebral infarcts in patients with sickle cell disease: a systematic review and meta-analysis. BMC Med. 2020;18(1):393.doi:10.1186/s12916-020-01864-8.
   PubMed Web of Science ®Google Scholar
• Kinney TR, Sleeper LA, Wang WC, et al. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The cooperative study of sickle cell disease. Pediatrics. 1999;103(3):640–645.doi:10.1542/peds.103.3.640.
   PubMed Web of Science ®Google Scholar
• Pegelow CH, Wang W, Granger S, et al. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Arch Neurol. 2001;58(12):2017–2021.doi:10.1001/archneur.58.12.2017.
   PubMedGoogle Scholar
• Jordan LC, Kassim AA, Donahue MJ, et al. Silent infarct is a risk factor for infarct recurrence in adults with sickle cell ­anemia. Neurology. 2018;91(8):e781–e784.doi:10.1212/WNL.0000000000006047.
   PubMed Web of Science ®Google Scholar
• Tantawy AAG, El Rakawy MH, Mohamed SA, et al. MRI brain in young Egyptian sickle cell disease patients: relation to cerebral blood flow and neuropsychometric evaluation. Haematologica.2015;100(s1):783.
   Google Scholar
• Marouf R, Gupta R, Haider MZ, et al. Silent brain infarcts in adult Kuwaiti sickle cell disease patients. Am J Hematol. 2003;73(4):240–243.doi:10.1002/ajh.10376.
   PubMed Web of Science ®Google Scholar
• Adekile AD, Yacoub F, Gupta R, et al. Silent brain infarcts are rare in Kuwaiti children with sickle cell disease and high Hb F. Am J Hematol. 2002;70(3):228–231.doi:10.1002/ajh.10143.
   PubMed Web of Science ®Google Scholar
• Brewin JN, Rooks H, Gardner K, et al. Genome wide association study of silent cerebral infarction in sickle cell disease (HbSS and HbSC). Haematologica. 2021;106(6):1770–1773.doi:10.3324/haematol.2020.265827.
   PubMed Web of Science ®Google Scholar
• do Kleyton Palmeira Ó, da Silva Freire AK, de Nóbrega DN, et al. Polymorphisms and gene expression of metalloproteinases and their inhibitors associated with cerebral ischemic stroke in young patients with sickle cell anemia. Mol Biol Rep. 2023;50(4):3341–3353.doi:10.1007/s11033-023-08262-2.
   PubMed Web of Science ®Google Scholar
• Earley EJ, Kelly S, Fang F, et al. Genome-wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel loci. Br J Haematol. 2023;201(2):343–352.doi:10.1111/bjh.18637.
   PubMed Web of Science ®Google Scholar
• Ford AL, Ragan DK, Fellah S, et al. Silent infarcts in sickle cell disease occur in the border zone region and are associated with low cerebral blood flow. Blood. 2018;132(16):1714–1723.doi:10.1182/blood-2018-04-841247.
   PubMed Web of Science ®Google Scholar
• Brousse V, Pondarre C, Kossorotoff M, et al. Brain injury pathophysiology study by a multimodal approach in children with sickle cell anemia with no intra or extra cranial arteriopathy. Haematologica. 2022;107(4):958–965.doi:10.3324/haematol.2020.278226.
   PubMed Web of Science ®Google Scholar
• Calvet D, Tuilier T, Mele N, et al. Low fetal hemoglobin percentage is associated with silent brain lesions in adults with homozygous sickle cell disease. Blood Adv. 2017;1(26):2503–2509.doi:10.1182/bloodadvances.2017005504.
   PubMed Web of Science ®Google Scholar
• Solomou E, Kraniotis P, Kourakli A, et al. Extent of silent cerebral infarcts in adult sickle-cell disease patients on magnetic resonance imaging: is there a correlation with the clinical severity of disease. ? Hematol Rep. 2013;5(1):8–12.
   PubMedGoogle Scholar
• Abboud MR, Yim E, Musallam KM, et al. Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II. Blood. 2011;118(4):894–898.doi:10.1182/blood-2010-12-326298.
   PubMed Web of Science ®Google Scholar